logo
  

Aviva Names Charlotte Jones CFO, Executive Director With Effect From Sept. 5

British insurer Aviva Plc (AV,AV.L) Monday announced the appointment of Charlotte Jones as Chief Financial Officer and Executive Director with effect from September 5.

Jones succeeds Jason Windsor, who is resigning from the company as Chief Financial Officer and as a Director with effect from July 2022, to take up the position of CFO at Persimmon.

Jones was previously Chief Financial Officer of RSA Insurance plc and Interim Chief Executive Officer of the RSA UK & International business. She was also CFO of Jupiter Fund Management plc. Before that she was Head of Group Finance at Credit Suisse Group and Deputy Group CFO at Deutsche Bank Group. She started her career at EY.

Amanda Blanc, Group Chief Executive Officer, said, "Charlotte is a highly experienced CFO with an impressive track record across the insurance and asset management industries. She is an exceptional addition to Aviva and will play a central role as we accelerate our performance and grow."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
RELATED NEWS
Follow RTT